Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,377,939
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
22,224,435
-
Shares change
-
+1,576,663
-
Total reported value, excl. options
-
$442,228,625
-
Value change
-
+$31,389,222
-
Number of buys
-
71
-
Number of sells
-
-39
-
Price
-
$19.9
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2018
133 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q4 2018.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,224,435 shares
of 46,377,939 outstanding shares and own 47.92% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5,926,878 shares), Vanguard Group Inc (2,288,409 shares), DIMENSIONAL FUND ADVISORS LP (1,901,231 shares), FEDERATED INVESTORS INC /PA/ (1,355,451 shares), Invesco Ltd. (1,112,867 shares), STATE STREET CORP (1,017,941 shares), TEACHERS ADVISORS, LLC (567,204 shares), NORTHERN TRUST CORP (473,437 shares), Bank of New York Mellon Corp (447,128 shares), and GEODE CAPITAL MANAGEMENT, LLC (425,301 shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.